Rasa has launched two coffee alternative mixes with adaptogenic herbs and mushrooms instead of caffeine, the Classic Rasa and Café Rasa.
Rasa CEO and founder, Lopa van der Mersch, said Classic Rasa, which is made of roasted chicory, burdock root, and date seed to create a dark, rich, and sweet blend, is the most coffee-like alternative out there.
It also has adaptogens: red Asian ginseng, cordyceps, rhodiola, gynostemma, shatavari, and maca.
Meanwhile, Café Rasa blends freeze-fried coffee from Chiapas, Mexico, with adaptogens that are said to soften coffee’s downsides whilst supplementing caffeine’s fatigue-fighting abilities.
According to van der Mersch, the two new mixes open new channels of distribution and provide everyone with the opportunity to drink Rasa.
Co-founder, Ben LeVine, added that their process includes brewing the herbs over several hours like a standard decoction, then drying it and granulating it to produce a supremely delicious, dissolvable, and bioavailable mix.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Why have so few atrocities ever been recognised as genocide?
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Debate over H-1B visas shines spotlight on US tech worker shortages
Why financial hardship is more likely if you’re disabled or sick
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 



